China Resources Medical Holdings Company Limited Cash Flow Reinvestment Rate

Latest as of June 2023: 0.57x

China Resources Medical Holdings Company Limited cash flow reinvestment rate. China Resources Medical Holdings Company Limited (1PH) has a Cash Flow Reinvestment Rate of 0.57x as of June 2023, reinvesting €155.33 Million (capex €96.85 Million plus investments €58.49 Million) from operating cash flow of €270.22 Million. Explore how well can China Resources Medical Holdings Company service its debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.57x
(Capex + Investments) / Operating CF

Total Reinvested

€155.33 Million
Capex + Investments

Operating Cash Flow

€270.22 Million
EUR

Capital Expenditures

€96.85 Million
EUR

Cash Flow Reinvestment Rate of China Resources Medical Holdings Company Limited (2016–2025)

Cash flow reinvestment rate of China Resources Medical Holdings Company Limited from 2016 to 2025. Historical reinvestment intensity for China Resources Medical Holdings Company Limited across 10 annual periods. Explore China Resources Medical Holdings Company capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

China Resources Medical Holdings Company Limited Cash Flow Reinvestment Rate by Year (2016–2025)

China Resources Medical Holdings Company Limited cash flow reinvestment rate by year from 2016 to 2025. Year-by-year capital reinvestment analysis for China Resources Medical Holdings Company Limited. For the full cash flow conversion analysis, see China Resources Medical Holdings Company operating cash flow efficiency.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.38x €514.94 Million €1.36 Billion €514.13 Million ▼ -14.7%
2024 0.44x €564.75 Million €1.27 Billion €563.69 Million ▼ -61.2%
2023 1.15x €1.37 Billion €1.20 Billion €486.68 Million ▲ +131.4%
2022 0.50x €310.21 Million €626.58 Million €252.87 Million ▼ -72.8%
2021 1.82x €1.29 Billion €710.43 Million €198.43 Million ▲ +216.8%
2020 0.58x €370.34 Million €643.69 Million €209.55 Million ▲ +21.9%
2019 0.47x €172.73 Million €366.05 Million €36.37 Million ▼ -61.1%
2018 1.21x €405.67 Million €334.15 Million €57.61 Million ▼ -6.6%
2017 1.30x €597.53 Million €459.54 Million €34.50 Million ▲ +78.7%
2016 0.73x €162.86 Million €223.79 Million €42.45 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow